logo

For the Inventor, By the Inventor

North Brunswick, NJ, United States of America

Pds Biotechnology Corporation


USPTO Granted Patents = 14


Trademarks = 4

Forward Citations = 186

Loading Chart...
Loading Chart...

22 inventors (with patents filed for the assignee):

goldMedal Frank Bedu-Addo (13 out of 14 patents)

silverMedal Leaf Huang (6 out of 42 patents)

bronzeMedal Kenya Johnson (6 out of 6 patents)

4.  Eric Jacobson (5 out of 8 patents)

5.  Gregory Conn (4 out of 4 patents)

6.  Martin Ward (3 out of 4 patents)

7.  Jerold Woodward (3 out of 5 patents)

8.  Samir N Khleif (3 out of 24 patents)

9.  Mikayel Mkrtichyan (3 out of 18 patents)

10.  Elizabeth Ann Vasievich (3 out of 3 patents)

11.  Kenya N Toney Johnson (3 out of 3 patents)

12.  Weihsu Claire Chen (3 out of 3 patents)

13.  Greg Conn (2 out of 3 patents)

14.  Weihsu Chen (2 out of 4 patents)

15.  Weili Yan (2 out of 2 patents)


14 patents:

1. 12551460 - METHODS AND COMPOSITIONS COMPRISING CATIONIC LIPIDS FOR STIMULATING TYPE 1 INTERFERON GENES (2026-02-17),
2. 12201685 - Methods of modulating immune responses with cationic lipid vaccine compositions (2025-01-21),
3. 11911465 - Vaccine compositions and methods of use (2024-02-27),
4. 11911359 - Stimulation of an immune response by cationic lipids (2024-02-27),
5. 11904015 - Vaccine compositions and methods of use (2024-02-20),
6. 11801257 - Stimulation of an immune response by enantiomers of cationic lipids (2023-10-31),
7. 11612652 - Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy (2023-03-28),
8. 11401306 - HPV16 non HLA-restricted t-cell vaccines, compositions and methods of use thereof (2022-08-02),
9. 10828364 - Method for reducing a myeloid derived suppressor cell population with cationic lipid vaccine compositions (2020-11-10),
10. 10702541 - Stimulation of an immune response by enantiomers of cationic lipids (2020-07-07),
11. 10286064 - Cationic lipid vaccine compositions and methods of use (2019-05-14),
12. 9789129 - Stimulation of an immune response by enantiomers of cationic lipids (2017-10-17),
13. 8877206 - Stimulation of an immune response by cationic lipids (2014-11-04),
14. 7303881 - Antigen delivery compositions and methods of use (2007-12-04),
Company Overview
PDS Biotechnology Corporation is a clinical-stage biopharmaceutical company based in North Brunswick, NJ, specializing in the development of innovative immunotherapies for the treatment of cancer and infectious diseases. The company focuses on harnessing the power of the immune system to create effective therapeutic solutions, leveraging its proprietary technology platform to enhance immune responses. PDS Biotech aims to address significant unmet medical needs through its advanced research and development efforts in the biopharmaceutical sector.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Pds Biotechnology Corporation USPTO Patent Assignee Logo
14 Patents

#5 in North Brunswick, NJ

#844 in New Jersey

#22,333 in US

#42,290 in the World

North Brunswick, NJ (US)
North Brunswick, NJ, United States of America

Pds Biotechnology Corporation

Forward Citations = 186

22 inventors:

goldMedal Frank Bedu-Addo (13 out of 14 patents)

silverMedal Leaf Huang (6 out of 42 patents)

bronzeMedal Kenya Johnson (6 out of 6 patents)

4.  Eric Jacobson (5 out of 8 patents)

5.  Gregory Conn (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pds Biotechnology Corporation. Retrieved from https://idiyas.com/company/pds-biotechnology

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…